Genetic Engineering and Biotechnolgy News is one of the leading journals in biotechnology, showcasing groundbreaking technologies and the latest advanced in the biotech field.
Check out the latest article published at the prestigious journal and written by Gail Dutton, where our senior scientist Pilar Manrique, PhD has contributed with a nice pice.
In this new article entitle New Technologies Expand Microbe-Based Therapies Beyond the Gut, the potencial of microbial-derived biological medicines is well covered with different approaches and products. Novel microbiome therapies are not only designed to model the gut microbiome composition but instead are being developed to reprogram the immune system as a more direct approach to cure certain diseases. This new generation of therapeutics aims to overcome previous challenges such as low efficacy and short duration of effects. For example, using specific bacterial strains to activate immune pathways, enhancing the efficacy of existing treatments for oncology, inflammatory diseases and fighting infectious diseases.
Finally, the article emphasizes the importance of microbiome analysis standardization to ensure reproducibility and accuracy of microbiome research and speed up the development of efficacious biotherapies. Protocol normalization and standardization is key to develop microbiome-based diagnostics tool that are helpful in a clinical setting.
Link to the original article: https://www.genengnews.com/topics/omics/new-technologies-expand-microbe-based-therapies-beyond-the-gut/
